Metraipolis › archive › dc_3cd7cf9ad647
High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomas — Europe PMC PMID:40854877
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40854877
- DOI
- 10.1038/s41419-[numero omesso]-1
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T09:00:45.201Z
- SHA-256 of the archived text
39c7deab26273534cfe33b7d08dc0cc8f351b8826c2fa11d07a850f1bdbf4627- Stable URL of this page
https://metraipolis.com/documento/dc_3cd7cf9ad647
How to cite
High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomas — Europe PMC PMID:40854877 — Europe PMC (en), https://europepmc.org/article/MED/40854877 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3cd7cf9ad647 (Metraipolis archive dc_3cd7cf9ad647, sha256 39c7deab26273534cfe33b7d08dc0cc8f351b8826c2fa11d07a850f1bdbf4627)
BibTeX
@misc{dc3cd7cf9ad647,
title = {High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomas — Europe PMC PMID:40854877},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40854877},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3cd7cf9ad647; sha256 39c7deab26273534cfe33b7d08dc0cc8f351b8826c2fa11d07a850f1bdbf4627},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40854877. Agents can read the archived copy with the MCP tool read_document.